Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Conditions

Leiomyoma 3Prostatic Neoplasms 2Pregnancy Complications 2Endometriosis 2Uterine Neoplasms 1Uterine Hemorrhage 1Myoma 1Myofibroma 1

Interventions

relugolix 2ulipristal acetate 1Uterine Myomectomy 1Tablets 1Surgical Procedures, Operative 1Pregnancy 1Observation 1Norethindrone Acetate 1Estradiol 1Eating 1Cari-D-Tect 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Pregnancy Complications × relugolix × Clear all
NCT05739123 2025-08-19

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Sumitomo Pharma Switzerland GmbH

Recruiting
728 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

NCT05739136 2025-08-01

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland GmbH

Active not recruiting
530 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡